Prof Karin Hing
PhD, BSc, CEng, MIMMM, FHEA, FRSA, FWES

 

Current Funding

  • 3D perfusion bioreactor studentship Baxter - EPSRC DTP CASE Conversion 2021
    Karin Hing
    £30,000 Baxter Healthcare Corporation (21-09-2021 - 20-09-2025)
  • Bioresorbable bioactive composites Kick off
    Karin Hing and Emiliano Bilotti
    £50,243 Baxter Healthcare Corporation (11-01-2021 - 22-01-2025)
  • Sponsorship of P/T Student: Daniel Johnson
    Karin Hing
    £128,992 Apatech Ltd (01-02-2011 - 01-08-2026)

Recent Funding

  • KTP AKT (QMUL-Lucideon) - Radio Opaque Cements and Osteoclast Testing: Traceable Bio-Remodellable Cements
    Karin Hing and Simon Rawlinson
    £41,283 Innovate UK (25-03-2024 - 24-07-2024)
  • KTP with Lucideon: Cell testing to assist development of novel biomaterials
    Karin Hing and Simon Rawlinson
    £256,237 Innovate UK (17-02-2021 - 17-02-2024)
  • Bioactive bioresorbable composites for load bearing guided bone regeneration
    Karin Hing
    £29,000 Baxter Healthcare Corporation (01-10-2020 - 30-09-2024)
  • Development of mechanically enhanced osteoinductive synthetic bone graft substitutes
    Karin Hing
    £87,500 Apatech Ltd (01-10-2017 - 31-03-2022)
  • Doctoral Educational Research Agreement
    Karin Hing
    £79,714 Baxter Healthcare Corporation (01-01-2015 - 31-03-2022)